Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A trial to investigate ribavirin treatment patterns and safety of ombitasvir/paritaprevir/ritonavir with or Without dasabuvir in HCV GT1 and GT4-infected patients enrolled in the German Hepatitis C Registry (DHC-R).

Next Previous
Search
Trial Profile

A trial to investigate ribavirin treatment patterns and safety of ombitasvir/paritaprevir/ritonavir with or Without dasabuvir in HCV GT1 and GT4-infected patients enrolled in the German Hepatitis C Registry (DHC-R).

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 15 Nov 2017

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Ombitasvir/paritaprevir/ritonavir (Primary) ; Ribavirin (Primary) ; Dasabuvir
  • Indications Hepatitis C
  • Focus Adverse reactions
  • Acronyms DHC-R

    • Most Recent Events

    • 24 Oct 2017 Results (n=340) assessing frequency of co-morbidities and the clinical relevance of drug drug interactions between the regular medications and elbasvir/grazoprevir in patients with chronic HCV GT1 infection presented at The Liver Meeting 2017: 68th Annual Meeting of the American Association for the Study of Liver Diseases
    • 24 Oct 2017 Results (n=4061) of analysis assessing SVR12 rates for patients with and without opioid substitution therapy presented at The Liver Meeting 2017: 68th Annual Meeting of the American Association for the Study of Liver Diseases
    • 16 May 2016 New trial record

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top